Clinical trial
Alpha-galactosidase Enzyme and Irritable Bowel Syndrome
NCT01243853 is registered in ClinicalTrials.gov with Verman Oy Ab as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Alpha-galactosidase Enzyme and Irritable Bowel Syndrome
- Lead sponsor
- Verman Oy Ab
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- December 31, 2010
- Completion date
- February 29, 2012
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.